ST. LOUIS -- Nuclear medicine scanning will be enriched with the introduction of GE Healthcare's Discovery*^ NM/CT 670 Pro, announced today at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2014). The vision of quantitative accuracy in nuclear medicine is enabled by Q.Metrix^ and Q.AC^, GE Healthcare's newest software innovations in nuclear medicine.
business unit
tags
ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.
business unit
tags
HOUSTON---June 3, 2014---GE (NYSE: GE) today announced that it has successfully completed its acquisition of Cameron's Reciprocating Compression division for $550 million USD.
The division provides reciprocating compression equipment and aftermarket parts and services for oil and gas production, gas processing, gas distribution and independent power industries. Cameron's Reciprocating Compression division has approximately 900 employees and operates from 20 global locations.
business unit
tags
TREVOSE, PA.---May 27, 2014---GE (NYSE: GE) today announced that the Swedish company WIBAX Energy AB, part of the WIBAX Group, will distribute GE's water technologies in the Nordic region. The distribution agreement, which started on May 1, 2014, combines WIBAX's local expertise and GE's advanced technologies to create greater access to innovative water and process solutions in the Nordic region. The distribution agreement will cover Denmark, Sweden, Norway and Finland.
business unit
tags
Next-generation OligoProcess system has potential to help pharmaceutical industry save time and money
CHALFONT ST. GILES, UK and FRANKFURT, GERMANY -- 13 May 2014 -- GE Healthcare Life Sciences (NYSE: GE) and German oligonucleotide manufacturer BioSpring GmbH announced today that BioSpring has selected and installed GE Healthcare Life Sciences' OligoProcess, a fully automated oligonucleotide synthesizer, as a core element of its state-of-the-art production facility in Frankfurt.